These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 240179

  • 1. Correlation between plasma levels of prolactin and chlorpromazine in psychiatric patients.
    Kolakowska T, Wiles DH, McNeilly AS, Gelder MG.
    Psychol Med; 1975 May; 5(2):214-6. PubMed ID: 240179
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effect of intramuscular chlorpromazine on serum prolactin levels in schizophrenic patients and normal controls.
    Meltzer HY, Busch DA, Creese IR, Snyder SH, Fang VS.
    Psychiatry Res; 1981 Aug; 5(1):95-105. PubMed ID: 6944710
    [Abstract] [Full Text] [Related]

  • 5. Clinical significance of plasma drug and prolactin levels during acute chlorpromazine treatment: a replication study.
    Kolakowska T, Orr M, Gelder M, Heggie M, Wiles D, Franklin M.
    Br J Psychiatry; 1979 Oct; 135():352-9. PubMed ID: 519119
    [Abstract] [Full Text] [Related]

  • 6. Does a plasma level of chlorpromazine help?
    Van Putten T, May PR, Jenden DJ.
    Psychol Med; 1981 Nov; 11(4):729-34. PubMed ID: 6119719
    [Abstract] [Full Text] [Related]

  • 7. Serum neuroleptic and prolactin levels in schizophrenic patients and clinical response.
    Meltzer HY, Busch DA, Fang VS.
    Psychiatry Res; 1983 Aug; 9(4):271-83. PubMed ID: 6580660
    [Abstract] [Full Text] [Related]

  • 8. Effect of chlorpromazine treatment on prolactin levels in cerebrospinal fluid and plasma of psychotic patients.
    Wode-Helgodt B, Eneroth P, Fyrö B, Gullberg B, Sedvall G.
    Acta Psychiatr Scand; 1977 Oct; 56(4):280-93. PubMed ID: 335789
    [Abstract] [Full Text] [Related]

  • 9. Relationships between drug concentrations in serum and CSF, clinical effects and monoaminergic variables in schizophrenic patients treated with sulpiride or chlorpromazine.
    Alfredsson G, Bjerkenstedt L, Edman G, Härnryd C, Oxenstierna G, Sedvall G, Wiesel FA.
    Acta Psychiatr Scand Suppl; 1984 Oct; 311():49-74. PubMed ID: 6199949
    [Abstract] [Full Text] [Related]

  • 10. Relationships among clinical response, extrapyramidal syndrome and plasma chlorpromazine and metabolite ratios.
    Sakalis G, Chan TL, Sathananthan G, Schooler N, Goldberg S, Gershon S.
    Commun Psychopharmacol; 1977 Oct; 1(2):157-66. PubMed ID: 342185
    [No Abstract] [Full Text] [Related]

  • 11. Effect of a drug holiday on plasma chlorpromazine levels in chronic schizophrenic patients.
    Hershey LA, Gift T, Atkins RW, Rivera-Calimlim L.
    Psychopharmacology (Berl); 1981 Oct; 73(4):355-8. PubMed ID: 6789357
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Correlation between plasma chlorpromazine and its metabolites and clinical ratings in patients with acute relapse of schizophrenic and paranoid psychosis.
    Phillipson OT, McKeown JM, Baker J, Healey AF.
    Br J Psychiatry; 1977 Aug; 131():172-84. PubMed ID: 912219
    [Abstract] [Full Text] [Related]

  • 15. The use of a side effect as a qualitative indicator of plasma chlorpromazine levels.
    Chetty M, Gouws E, Miller R, Moodley SV.
    Eur Neuropsychopharmacol; 1999 Jan; 9(1-2):77-82. PubMed ID: 10082231
    [Abstract] [Full Text] [Related]

  • 16. Effects of trihexyphenidyl on plasma chlorpromazine in young schizophrenics.
    Rockland L, Cooper T, Schwartz F, Weber D, Sullivan T.
    Can J Psychiatry; 1990 Oct; 35(7):604-7. PubMed ID: 2268840
    [Abstract] [Full Text] [Related]

  • 17. Effects of sulpiride and chlorpromazine on depressive symptoms in schizophrenic patients--relationship to drug concentrations.
    Alfredsson G, Härnryd C, Wiesel FA.
    Psychopharmacology (Berl); 1984 Oct; 84(2):237-41. PubMed ID: 6438683
    [Abstract] [Full Text] [Related]

  • 18. Variability of response to neuroleptics in schizophrenia: clinical, pharmacologic, and neuroendocrine correlates.
    Gelder M, Kolakowska T.
    Compr Psychiatry; 1979 Oct; 20(5):397-408. PubMed ID: 39704
    [No Abstract] [Full Text] [Related]

  • 19. Propranolol in schizophrenia. II. Clinical and biochemical aspects of combining propranolol with chlorpromazine.
    Peet M, Middlemiss DN, Yates RA.
    Br J Psychiatry; 1981 Aug; 139():112-7. PubMed ID: 7030443
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.